Institutional Manager · CIK 0001812549
RiverVest Venture Management LLC
St. Louis, MO · File #028-21321
Latest AUM
$6.8M
Positions
3
Top-10 Concentration
100.0%
Filings
4
Portfolio Value Over Time
2023-12
2024-03
2024-06
2024-09
Biggest QoQ Changes
Ranked by conviction flow (share change × current price) so mark-to-market moves don't dominate. Price effect column shows how much of the $ change was just the stock moving.
| Action | Issuer | Ticker / CUSIP | Δ Shares | Flow ($) | Price Effect |
|---|---|---|---|---|---|
| EXITED | Vapotherm, Inc. | 922107107 | -52,881 | -$112,282 | $0 |
| REDUCE | Spruce Bioscience, Inc. | 85209E109 | 0 | $0 | -$125,673 |
| REDUCE | Reneo Pharmaceuticals, Inc. | 75974E103 | 0 | $0 | +$481,502 |
| REDUCE | Xilio Therapeutics, Inc. | 98422T100 | 0 | $0 | -$230,343 |
Filing History
- 13F HOLDINGS REPORTQ/E Sep 20243 pos · $6.8M
- 13F HOLDINGS REPORTQ/E Jun 20244 pos · $6.8M
- 13F HOLDINGS REPORTQ/E Mar 20244 pos · $8.1M
- 13F HOLDINGS REPORTQ/E Dec 20235 pos · $40.4M
Top 3 Holdings — Sep 2024
| # | Issuer | Ticker | Shares | Value | % of Portfolio |
|---|---|---|---|---|---|
| 1 | Reneo Pharmaceuticals, Inc. | 75974E103 | 2,534,220 | $4.3M | 63.00% |
| 2 | Spruce Bioscience, Inc. | 85209E109 | 2,936,281 | $1.4M | 20.39% |
| 3 | Xilio Therapeutics, Inc. | 98422T100 | 1,441,444 | $1.1M | 16.60% |